Reference Library

Advocacy Documents

NASP’s Comments on HHS Blueprint & Request for Information

A Tangled Web – An Examination of the Drug Supply and Payment Chains

Medicare Program; Contract Year 2019 Policy and Technical Changes to the Medicare Advantage, Medicare Cost Plan, Medicare Fee-for-Service, the Medicare Prescription Drug Benefit Programs, and the PACE Program

Announcement of Calendar Year (CY) 2019 Medicare Advantage Capitation Rates and Medicare Advantage and Part D Payment Policies and Final Call Letter

CMS Finalizes Policy Changes and Updates for Medicare Advantage and the Prescription Drug Benefit Program for Contract Year 2019 (CMS-4182-F)

2019 Medicare Advantage and Part D Rate Announcement and Call Letter

NASP’s Comments to CMS’ Proposed Rule and 2019 Draft Call Letter

NASP submits comments to CMS on Medicare Proposed Rule for Contract Year 2019

CMS Proposed Rule on Part D – November 16th, 2017

NASP’s comments to CMS’ Proposed Medicare Part D DIR Reporting Requirements for 2016

NASP Response to the 2017 Transformation Ideas in Response to Final Part D Call Letter’s Request for Information (RFI)

NASP Response Advance Notice of Methodological Changes for Calendar Year (201) for Medicare Advantage (MA) Capitation Rates, Part C and Part D Payment Policies and 201 Call Letter

Any Willing Pharmacy (AWP) Changes Are Needed to Improve Beneficiary Access to Specialty Pharmacies

Overview of AWP Provisions for 2017 Contract Year

Overview of 2017 Direct and Indirect Remuneration Fees

DIR Fees Increase Medicare Beneficiary and Medicare Program Costs for Specialty Drugs

NASP Definitions of Specialty Pharmacy and Specialty Medications

 

We’ve updated our privacy policy, including to provide further detail about how we collect, protect, use, and share personal data. Click here to view the privacy policy.

Top